GSE123825 2 V 3 GLUTAMINE MOUSE DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE123825 2 V 3 GLUTAMINE MOUSE DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE123825 2 V 3 GLUTAMINE MOUSE DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE123825 2 V 3 GLUTAMINE MOUSE DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE123825 2 V 3 GLUTAMINE MOUSE DN.

Results found

Linked to

 

Label

Description

 

Gene

RAD52 motif containing 1

Gene

PHD finger protein 12

Gene

BPI fold containing family B member 3

Gene

carnitine palmitoyltransferase 1C

Gene

gamma-glutamyltransferase 5

Gene

patched domain containing 1

Gene

SFT2 domain containing 2

Gene

euchromatic histone lysine methyltransferase 1

Gene

holocarboxylase synthetase

Gene

shiftless antiviral inhibitor of ribosomal frameshifting

  • Gene

    RAD52 motif containing 1


  • Gene

    PHD finger protein 12


  • Gene

    BPI fold containing family B member 3


  • Gene

    carnitine palmitoyltransferase 1C


  • Gene

    gamma-glutamyltransferase 5


  • Gene

    patched domain containing 1


  • Gene

    SFT2 domain containing 2


  • Gene

    euchromatic histone lysine methyltransferase 1


  • Gene

    holocarboxylase synthetase


  • Gene

    shiftless antiviral inhibitor of ribosomal frameshifting

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.